Showing results (331-340 of 388) with videos related to
Sort By:
Pageof 39
Diabetes & Vascular Disease Research|March 3, 2022
Diabetes mellitus and the causes of hospitalisation in people with heart failureAnam Malik, Ellis Garland, Michael Drozd, et al.Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.BMC Cardiovascular Disorders|January 25, 2023
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the USMitchell S V Elkind, Klaus K Witte, Scott E Kasner, et al.BMJ Open|July 20, 2019
Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.Diabetes Care|October 7, 2017
Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With DiabetesKlaus K Witte, Michael Drozd, Andrew M N Walker, et al.Journal of the American Heart Association|October 30, 2018
Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection FractionAndrew M N Walker, Michael Drozd, Marlous Hall, et al.Journal of the American Heart Association|October 30, 2018
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionBen N Mercer, Aaron Koshy, Michael Drozd, et al.European Heart Journal|June 3, 2017
Remote management of heart failure using implantable electronic devicesJohn M Morgan, Sue Kitt, Jas Gill, et al.BMJ Open|April 27, 2026
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USAMatthew R Reynolds, Vicki Pollit, Lee Schwamm, et al.European Heart Journal. Cardiovascular Imaging|October 14, 2017
Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trialJames R J Foley, Peter P Swoboda, Graham J Fent, et al.Pageof 39